文献速递糖尿病

青年起病1型和2型糖尿病向成年过渡期HbA1c检测差异及其与糖尿病结局的关联:SEARCH研究

Disparities in Hemoglobin A1c Testing During the Transition to Adulthood and Association With Diabetes Outcomes in Youth-Onset Type 1 and Type 2 Diabetes: The SEARCH for Diabetes in Youth Study.
PubMed 文献 · Diabetes Care · 2021-01-01

SEARCH研究纳入青年起病1型(8年病程n=1,885;13年病程n=649)和2型糖尿病(8年病程n=230;13年病程n=84)患者,分析HbA1c检测频率的相关因素及其与HbA1c水平和微血管并发症的关联。1型糖尿病中,诊断年龄较大、病程较长、无个人医生和保险中断与每年≥3次HbA1c检测的 odds 降低相关;检测频率≥3次/年与13年病程时较低HbA1c水平和较低微血管并发症 odds 相关,但校正检测相关因素后关联减弱。2型糖尿病中,未就诊内分泌科医生降低检测频率 odds,但检测频率与HbA1c水平或微血管并发症无关联。

要点

  • 1型糖尿病中,无个人医生和保险中断与HbA1c检测频率不足相关。
  • 1型糖尿病中,检测≥3次/年与13年病程时较低HbA1c和微血管并发症风险相关。
  • 2型糖尿病中,未就诊内分泌科医生与HbA1c检测频率不足相关。

核心结论

  • HbA1c检测频率的差异主要由医疗保健相关因素导致,且在1型糖尿病中与糖尿病结局相关。

研究设计与样本

  • SEARCH for Diabetes in Youth研究收集了8年病程(1型n=1,885,2型n=230)和13年病程(1型n=649,2型n=84)患者的 data。
  • 使用逻辑回归识别每年报告≥3次HbA1c检测的相关因素,并用序贯调整的线性和逻辑回归分析检测与HbA1c水平及微血管并发症的关联。

主要发现

  • 1型糖尿病中,诊断年龄较大(OR 0.91 [95% CI 0.88-0.95])、病程较长(OR 0.90 [0.82-0.99])、无个人医生(OR 0.44 [0.30-0.65])和保险中断(OR 0.51 [0.27-0.96])与报告≥3次HbA1c检测/年的 odds 降低相关。
  • 1型糖尿病中,随时间推移HbA1c检测≥3次/年与13年病程时较低HbA1c水平(OR -0.36% [-0.65 to -0.06])和较低微血管并发症 odds(OR 0.64 [0.43-0.97])相关,但校正检测相关因素后关联减弱(OR -0.17 [-0.46 to 0.13] 和 0.70 [0.46-1.07])。
  • 2型糖尿病中,未就诊内分泌科医生降低报告≥3次HbA1c检测/年的 odds(OR 0.19 [0.06-0.63]),但HbA1c检测频率与HbA1c水平或微血管并发症无关联。

临床怎么用

  • 对于青年起病1型糖尿病患者,应关注无个人医生和保险中断等医疗保健因素,以改善HbA1c检测频率。
  • 对于青年起病2型糖尿病患者,内分泌科就诊与更高的HbA1c检测频率相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify correlates of hemoglobin A1c (HbA1c) testing frequency and associations with HbA1c levels and microvascular complications in youth-onset diabetes. RESEARCH DESIGN AND METHODS: The SEARCH for Diabetes in Youth study collected data from individuals diagnosed with diabetes before age 20 at 8 years (n = 1,885 type 1, n = 230 type 2) and 13 years (n = 649 type 1, n = 84 type 2) diabetes duration. We identified correlates of reporting ≥3 HbA1c tests/year using logistic regression. We examined associations of HbA1c testing with HbA1c levels and microvascular complications (retinopathy, neuropathy, or nephropathy) using sequentially adjusted linear and logistic regression. RESULTS: For type 1 diabetes, odds of reporting ≥3 HbA1c tests/year at 8 and 13 years diabetes duration decreased with older age at diagnosis (odds ratio [OR] 0.91 [95% CI 0.88-0.95]), longer duration of diabetes (OR 0.90 [0.82-0.99]), not having a personal doctor (OR 0.44 [0.30-0.65]), and lapses in health insurance (OR 0.51 [0.27-0.96]). HbA1c testing ≥3 times/year over time was associated with lower HbA1c levels (OR -0.36% [-0.65 to -0.06]) and lower odds of microvascular complications (OR 0.64 [0.43-0.97]) at 13 years' duration, but associations were attenuated after adjustment for HbA1c testing correlates (OR -0.17 [-0.46 to 0.13] and 0.70 [0.46-1.07], respectively). For type 2 diabetes, not seeing an endocrinologist decreased the odds of reporting ≥3 HbA1c tests/year over time (OR 0.19 [0.06-0.63]), but HbA1c testing frequency was not associated with HbA1c levels or microvascular complications. CONCLUSIONS: We observed disparities in HbA1c testing frequency predominately by health care-related factors, which were associated with diabetes outcomes in type 1 diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Sauder KA, Stafford JM, Ehrlich S, et al. Disparities in Hemoglobin A1c Testing During the Transition to Adulthood and Association With Diabetes Outcomes in Youth-Onset Type 1 and Type 2 Diabetes: The SEARCH for Diabetes in Youth Study. Diabetes Care. 2021. PMID: 34376501. doi:10.2337/dc20-2983

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。